Actinium Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsActinium Pharmaceuticals

Actinium Pharmaceuticals(ATNM)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Mycophenolate sodium

,

myeloid leukemia acute

,

myeloid leukemia

Mycophenolic acid

,

myeloid leukemia acute

,

myeloid leukemia

,

mantle-cell lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

myelodysplastic syndromes

,

multiple myeloma

,

plasma cell neoplasms

,

myeloid leukemia acute

,

myeloid leukemia

,

,

,

monocytic leukemia acute

,

disease progression

,

myeloid leukemia acute

,

residual neoplasm

,

electrocardiography

,

pharmacokinetics

,

healthy volunteers/patients

sickle cell anemia

,

,

colonic neoplasms

,

,

systemic lupus erythematosus

,

colorectal neoplasms

,

agammaglobulinemia

,

primary immunodeficiency diseases

,

von willebrand diseases

,

alzheimer disease

,

graft vs host disease

,

thrombocytopenic purpura idiopathic

,

protein c deficiency

,

,

myeloid leukemia acute

,

non-hodgkin lymphoma

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

b-cell chronic lymphocytic leukemia

,

hodgkin disease

,

b-cell lymphoma marginal zone

,

follicular lymphoma

,

mantle-cell lymphoma

,

myeloid leukemia chronic-phase

,

large b-cell lymphoma diffuse

,

myeloid leukemia accelerated phase

,

burkitt lymphoma

,

large-cell lymphoma immunoblastic

,

,

thrombotic thrombocytopenic purpura

,

chronic obstructive pulmonary disease

,

,

mucocutaneous lymph node syndrome

,

immunologic deficiency syndromes

,

,

alpha 1-antitrypsin deficiency

,

,

healthy volunteers/patients

human influenza

,

,

,

enterovirus infections

Microcrystalline cellulose

,

muscular atrophy

,

,

,

hiv-associated lipodystrophy syndrome

,

colorectal neoplasms

,

,

chronic obstructive pulmonary disease

,

ulcerative colitis

,

,

,

respiratory tract diseases

,

respiration disorders

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

,

healthy volunteers/patients

,

,

human influenza

,

,

falciparum malaria

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

non-hodgkin lymphoma

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

prehypertension

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

neisseria meningitidis

,

haemophilus infections

,

,

type 2 diabetes mellitus

,

,

,

diabetes mellitus

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

,

communicable diseases

,

,

,

,

haemophilus influenzae type b

,

,

renal insufficiency

,

,

,

,

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

immunologic tests

Potassium magnesium citrate (4:1:2)

,

,

corneal diseases

,

,

,

myeloid leukemia acute

b-cell lymphoma

,

hodgkin disease

,

breast neoplasms

,

,

,

chemotherapy-induced febrile neutropenia

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

non-hodgkin lymphoma

,

mantle-cell lymphoma

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use